Tumor-to-background Ratio to Predict Response to Chemotherapy of Osteosarcoma Better than Standard Uptake Values

18F-FDG PET SUVmax as an indicator of histopathologic response after neoadjuvant chemotherapy in extremity osteosarcoma

(2013) Chang-Bae Kong et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Prediction of tumour necrosis fractions using metabolic and volumetric 18F-FDG PET/CT indices, after one course and at the completion of neoadjuvant chemotherapy, in children and young adults with osteosarcoma

(2011) Hyung Jun Im et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Assessment of Chemotherapy Response Using FDG-PET in Pediatric Bone Tumors: A Single Institution Experience

(2011) Dong Hwan Kim et al.   Cancer Research and Treatment

Assessment of histological response of paediatric bone sarcomas using FDG PET in comparison to morphological volume measurement and standardized MRI parameters

(2010) Timm Denecke et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

PET imaging of blood flow and glucose metabolism in localized musculoskeletal tumors of the extremities

(2010) Paula Lindholm et al.   NUCLEAR MEDICINE AND BIOLOGY

Evaluation of chemotherapy response in osteosarcoma with FDG-PET

(2009) Kenichiro Hamada et al.   ANNALS OF NUCLEAR MEDICINE

[F-18]-fluorodeoxy-D-glucose-positron emission tomography response is associated with outcome for extremity osteosarcoma in children and young adults

(2009) Douglas S. Hawkins et al.   CANCER

Prediction Model of Chemotherapy Response in Osteosarcoma by 18F-FDG PET and MRI

(2009) G. J. Cheon et al.   JOURNAL OF NUCLEAR MEDICINE

Response of osteogenic sarcoma to neoadjuvant therapy: evaluated by 18F-FDG-PET

(2008) Zhaoming Ye et al.   ANNALS OF NUCLEAR MEDICINE